These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 27103259)
1. Gamma glutamyltransferase and risk of future dementia in middle-aged to older Finnish men: A new prospective cohort study. Kunutsor SK; Laukkanen JA Alzheimers Dement; 2016 Sep; 12(9):931-941. PubMed ID: 27103259 [TBL] [Abstract][Full Text] [Related]
2. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study. Kunutsor SK; Khan H; Laukkanen JA J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068 [TBL] [Abstract][Full Text] [Related]
3. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study. Kunutsor SK; Laukkanen JA Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848 [TBL] [Abstract][Full Text] [Related]
4. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence. Kunutsor SK; Laukkanen JA; Bluemke DA; Butler J; Khan H Eur J Prev Cardiol; 2016 Sep; 23(13):1354-62. PubMed ID: 27084895 [TBL] [Abstract][Full Text] [Related]
5. Gamma-Glutamyltransferase and Future Risk of Pneumonia: A Long-Term Prospective Cohort Study. Kunutsor SK; Laukkanen JA Lung; 2017 Dec; 195(6):799-803. PubMed ID: 28993933 [TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase and risk of chronic kidney disease: A prospective cohort study. Kunutsor SK; Laukkanen JA Clin Chim Acta; 2017 Oct; 473():39-44. PubMed ID: 28811239 [TBL] [Abstract][Full Text] [Related]
7. Gamma-Glutamyl Transferase Variability and Risk of Dementia in Diabetes Mellitus: A Nationwide Population-Based Study. Hong SH; Han K; Park S; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Yoo HJ J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31955208 [TBL] [Abstract][Full Text] [Related]
8. Is lipoprotein (a) protective of dementia? Kunutsor SK; Khan H; Nyyssönen K; Laukkanen JA Eur J Epidemiol; 2016 Nov; 31(11):1149-1152. PubMed ID: 27412033 [TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study. Nano J; Muka T; Ligthart S; Hofman A; Darwish Murad S; Janssen HLA; Franco OH; Dehghan A Int J Epidemiol; 2017 Oct; 46(5):1400-1409. PubMed ID: 28338987 [TBL] [Abstract][Full Text] [Related]
10. Circulating gamma glutamyltransferase and prediction of cardiovascular disease. Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268 [TBL] [Abstract][Full Text] [Related]
11. Gamma-glutamyl transferase variability and risk of dementia: A nationwide study. Lee YB; Han K; Park S; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Yoo HJ Int J Geriatr Psychiatry; 2020 Oct; 35(10):1105-1114. PubMed ID: 32392636 [TBL] [Abstract][Full Text] [Related]
12. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys. Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154 [TBL] [Abstract][Full Text] [Related]
13. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Lee DH; Silventoinen K; Hu G; Jacobs DR; Jousilahti P; Sundvall J; Tuomilehto J Eur Heart J; 2006 Sep; 27(18):2170-6. PubMed ID: 16772340 [TBL] [Abstract][Full Text] [Related]
14. Association between γ-glutamyltransferase level and incidence of atrial fibrillation: A nationwide population-based study. Lee SR; Choi EK; Han KD; Cha MJ; Oh S Int J Cardiol; 2017 Oct; 245():149-155. PubMed ID: 28757090 [TBL] [Abstract][Full Text] [Related]
15. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402 [TBL] [Abstract][Full Text] [Related]
16. Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland. Wang Y; Tuomilehto J; Jousilahti P; Salomaa V; Li B; Antikainen R; Mähönen M; Katzmarzyk PT; Hu G Heart; 2013 Feb; 99(3):163-7. PubMed ID: 23144292 [TBL] [Abstract][Full Text] [Related]
17. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H; Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419 [TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414 [TBL] [Abstract][Full Text] [Related]
19. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Meisinger C; Döring A; Schneider A; Löwel H; Atherosclerosis; 2006 Dec; 189(2):297-302. PubMed ID: 16483579 [TBL] [Abstract][Full Text] [Related]
20. Gamma-Glutamyltransferase (GGT) as a biomarker of cognitive decline at the end of life: contrasting age and time to death trajectories. Praetorius Björk M; Johansson B Int Psychogeriatr; 2018 Jul; 30(7):981-990. PubMed ID: 29108523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]